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Long non-coding RNAs (lncRNAs) play critical and complicated roles in the regulation
of various biological processes, including chromatin modification, transcription and
post-transcriptional processing. Interestingly, some lncRNAs serve as miRNA “sponges”
that inhibit interaction with miRNA targets in post-transcriptional regulation. We
constructed a putative competing endogenous RNA (ceRNA) network by integrating
lncRNA, miRNA and mRNA expression based on high-throughput RNA sequencing and
microarray data to enable a comparison of the SHEE and SHEEC cell lines. Using
Targetscan and miRanda bioinformatics algorithms and miRTarbase microRNA-target
interactions database, we established that 51 miRNAs sharing 13,623 MREs with 2260
genes and 82 lncRNAs were involved in this ceRNA network. Through a biological
function analysis, the ceRNA network appeared to be primarily involved in cell
proliferation, apoptosis, the cell cycle, invasion and metastasis. Functional pathway
analyses demonstrated that the ceRNA network potentially modulated multiple
signaling pathways, such as the MAPK, Ras, HIF-1, Rap1, and PI3K/Akt signaling
pathways. These results might provide new clues to better understand the regulation
of the ceRNA network in cancer.
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Human esophageal cancer is the sixth leading cause of cancer-related death worldwide
[1]. The most frequent subtype, esophageal squamous cell carcinoma (ESCC), has an
obvious geographic variation in its distribution, with eastern Asia being a high inci-
dence area [1, 2]. Most ESCC patients are diagnosed at an advanced stage, past the
best opportunity for surgical treatment, and their overall 5-year survival rate is less
than 15 %. By contrast, patients diagnosed at an early stage can have 10-year overall
post-operative survival rates up to 95 % [3].
The immortalized human esophageal epithelial cell line SHEE and the malignantly trans-
formed esophageal carcinoma cell line SHEEC were established and cultured in consecutive
passes by Zeng Yi of the National Institute for Viral Disease Control and Prevention and
Shen Zhongying of the Medical College of Shantou University [4, 5]. From a biological per-
spective, SHEE is similar to a primary cell line and retains its proliferation ability and© 2016 The Author(s). Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International
License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium,
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and
indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
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in a monolayer and anchorage-dependent cell aggregation without colony formation in soft
agar or tumor formation after transplantation. SHEEC was established through induction of
the SHEE cell line using 12-otetradeanoy-lphorbol-13-acetate (TPA). These two cell lines
are the most appropriate models for ESCC tumorigenesis.
To date, considerable research has indicated that differential expression of miRNAs
has been observed in various types of human cancers, such as lung cancer, gastric can-
cer, breast cancer, colorectal cancer and ESCC [6–9]. The expression of miRNAs has
been used as a useful biomarker for tumor prognosis and clinical treatment. Micro-
RNAs can also regulate gene expression at the epigenetic regulation level. They are in-
volved in most aspects of cellular processes, including development, differentiation,
growth and apoptosis [10, 11].
Unlike small ncRNAs, increasing evidence indicates that lncRNAs play critical and com-
plicated roles in the regulation of various biological processes, including chromatin modifi-
cation, transcription and post-transcriptional processing [12–15]. Interestingly, additional
studies have revealed that some lncRNAs can serve as miRNA “sponges” that inhibit inter-
action with their miRNA targets in post-transcriptional regulation. This means they can be
considered competing endogenous RNA (ceRNA). Through gene expression data analysis,
Sumazin et al. found >7000 transcripts acting as ceRNAs in glioblastoma tissues [16].
Cesana et al. [17] revealed the ceRNA function of linc-MD1, which liberates the differenti-
ation factors MEF2C and MAML1 from repression by decoying miR-135 and -133 to con-
trol muscle differentiation. Another lncRNA, linc-RoR, acts as an endogenous sponge to
mediate miR-145 regulation of self-renewal of human embryonic stem cells [18, 19]. Inter-
estingly, CHRF, a lncRNA connected to cardiac hypertrophy-related factor, was found to act
as an endogenous sponge of miR-489, directly binding to and downregulating miR-489 ex-
pression levels and, in turn, regulating its targetMyd88 expression and hypertrophy [20].
The above studies identified a new regulatory mechanism in post-transcriptional
regulation: ceRNA networks. The mechanism of the ceRNA network is that all types of
RNA transcripts (lncRNA, pseudogenes and circular RNAs) could communicate with
each other by competing for binding to shared miRNA-binding sites (MREs) [21].
In this study, we constructed a putative competing endogenous RNA (ceRNA) net-
work by integrating lncRNA, miRNA and mRNA expression based on high-throughput
RNA sequencing and microarray data to enable a comparison of the SHEE and SHEEC
cell lines. Using Targetscan and miRanda bioinformatics algorithms and the miRTar-
base microRNA–target interactions database, we established that 51 miRNAs sharing
13,623 MREs with 2260 genes and 82 lncRNAs were involved in this ceRNA network.
Based on a biological function analysis, this ceRNA network may participate in the
PI3K/Akt pathway and, consistent with previous reports, may play a modulating role in
the regulation of stem-like cells in primary ESCC [22]. These results might provide
new clues to better understand the regulation of the ceRNA network in cancer.Materials and methods
Sample preparation
SHEE and SHEEC cells were cultured in Gibco MEM medium supplemented with
100 ml/l fetal bovine serum (containing 100 μg/ml penicillin and 100 μg/ml streptomycin)
Sun et al. Cellular & Molecular Biology Letters  (2016) 21:21 Page 3 of 13and incubated at 37 °C in a humidified atmosphere of 50 ml/l CO2. Cells were harvested
after growth into a full monolayer and were kept at −70 °C until use.Total RNA isolation
Total RNA from each sample was extracted using a TRK-1001 Total RNA Purification
Kit (LC Sciences) according to the manufacturer’s protocol. Total RNA was quantified
on a NanoDrop ND-2000 (Thermo Scientific), and the RNA integrity was assessed
using an Agilent Bioanalyzer 2100 (Agilent Technologies).μParaflo microRNA microarray assay
The microarray assay was performed by a service provider (LC Sciences). The assay
started with a 2 to 5 μg total RNA sample that was 3′-extended with a poly(A) tail
using poly(A) polymerase. An oligonucleotide tag was then ligated to the poly(A) tail
for later fluorescent dye staining. Hybridization was performed overnight on a μPara-
flo microfluidic chip using a microcirculation pump (Atactic Technologies) [23, 24].
On the microfluidic chip, each detection probe consisted of a chemically modified
nucleotide-coding segment complementary to the target microRNA (from miRBase
20.0, http://www.mirbase.org/) or other RNA (control or customer-defined se-
quences) and a spacer segment of polyethylene glycol to extend the coding segment
away from the substrate.
The detection probes were made via in situ synthesis using PGR (photogenerated re-
agent) chemistry. The hybridization melting temperatures were balanced by chemical
modifications of the detection probes. Hybridization used 100 l 6× SSPE buffer consist-
ing of 0.90 M NaCl, 60 mM Na2HPO4, 6 mM EDTA (pH 6.8) and 25 % formamide at
34 °C. After RNA hybridization, tag-conjugating Cy3 dye was circulated through the
microfluidic chip for dye staining. Fluorescence images were collected using a laser
scanner (GenePix 4000B, Molecular Device) and digitized using Array-Pro image ana-
lysis software (Media Cybernetics).
Data were analyzed by first subtracting the background, and then normalizing the
signals using a LOWESS filter (locally weighted regression) [25]. The miRNA differen-
tial expression based on the normalized signal was analyzed via selective application of
Student’s t test. The significance threshold was p < 0.05 and fold-change >2.Construction of cDNA libraries and high-throughput sequencing
To construct the next-generation sequencing libraries, approximately 3 μg of total
RNA was used to deplete ribosomal RNA according to the manufacturer’s protocol for
the Human/Mouse/Rat Ribo-Zero rRNA Removal Kit (Epicentre/Illumina). Following
purification, the poly(A)- or poly(A) + RNA fractions were fragmented into small pieces
using divalent cations at elevated temperatures. The cleaved RNA fragments were re-
verse transcribed to construct a cDNA library using the dUTP method as described
previously [26]. The average insert size for the paired-end libraries was 300 bp
(±50 bp). RNA libraries were then sequenced on the Illumina HiSeq 2500 platform
using 125-bp paired-end reads at LC Biotech in Hangzhou, China.
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The RNAseq data were aligned to hg19 using TopHat v2.0.9 [27] with the default pa-
rameters. The mapped reads were assembled using Cufflinks v2.11 [28, 29]. All multiple
assembled transcript files (GTF format) were then merged to produce a unique tran-
scriptome set using the Cuffmerge utility provided in the Cufflinks package [30].
We filtered the assembled novel transcripts from the two pooled cell lines to obtain
putative lncRNAs. First, identical and overlapping transcripts were merged to remove
redundancy. Then, transcripts overlapping with known gene exons were removed. Only
transcripts with a length >200 nt were retained. To identify and eliminate potential
known lncRNA transcripts, we compared the merged transcriptome with lncRNA and
protein-coding genes in the public authoritative database GENCODE [31].
To obtain a reliable dataset of putative lncRNAs, single exon models were filtered out.
Next, we removed transcripts that were likely to be assembly artifacts or PCR run-on frag-
ments according to their class code (annotated by Cuffmerge). Among the different clas-
ses defined by Cufflinks [32], only those annotated by “u”, “i”, “x”, “o” and “j” were
retained. Extremely low gene expression is generally considered to be transcriptional noise
[33]. On average, 79 % of the initial reads with a quality score >30 could be aligned to the
hg19 assembly of the human genome sequence. We used CPC (http://cpc.cbi.pku.edu.cn)
[34] and the coding non-coding index (CNCI) [35] to assess the protein-coding potential
of each novel transcript. Those putative transcripts with a CPC score < −1 and a CNCI
score < −1 were retained as candidate lncRNAs for further analysis.Transcript differential expression analysis
Expression levels of all of the transcripts, including putative lncRNAs and mRNAs,
were quantified as fragments per kilobase of exon per million fragments mapped
(FPKM) using the Cuffdiff program from the Cufflinks package. Differential gene ex-
pression was determined using Cuffdiff with a p-value of <0.05 and q-value of <0.05.Construction of ceRNA network
The putative miRNA–lncRNA interactions were evaluated using the algorithms of
Targetscan version 6.2 (http://www.targetscan.org/) and miRanda version 3.3a (http://
www.microrna.org/microrna/home.do). The miRNA binding-site prediction in lncRNAs
was based on their full-length sequence in consideration of their non-coding properties.
High-confidence miRNA–lncRNA pairs had a Targetscan context+ score percentile >50
and miRanda max energy < −20. To reduce the false positives, at least two miRNA
binding-sites were retained with each lncRNA. The mRNAs that were targeted by miR-
NAs with experimental support were from miRTarbase (http://mirtarbase.mbc.nctu.e-
du.tw/). The ceRNA relationships were integrated using an in-house Perl script. The
information including all of the above interactions was imported into Cytoscape software
version 3.3.0 (http://www.cytoscape.org) to construct a regulatory network.Results
Aberrantly expressed miRNAs
To make the preliminary determination of the miRNA expression differences between
the SHEE and SHEEC cell lines, their microarray profiles were determined though
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with 25 upregulated and 34 downregulated. All differentially expressed miRNAs
showed a >2.0-fold-change threshold and p < 0.05 (Fig. 1; Additional file 1).Aberrantly expressed lncRNAs and protein-coding genes
To systematically characterize the transcriptional changes between the SHEE and
SHEEC cell lines, we performed high-throughput RNA sequencing according to previ-
ously published methods [36–38]. Briefly, we generated >17 million reads from strand-
specific, paired-end, 125-bp RNAseq reads of total RNA depleted of rRNA from both
cell populations. Using TopHat [27], an average of 95 % clean reads were mapped to
the human GRCh38 genome (http://www.gencodegenes.org/releases/21.html). Using
the lncRNA discovery pipeline described in the Methods section above, we detected
11,557 unique protein-coding genes and 15,932 unique lncRNAs that met the criteria
of FPKM > 1 and length >200 nucleotides.Fig. 1 A heatmap of differentially expressed miRNAs depicting miRNAs differentially expressed in the SHEE
and SHEEC cell lines with a fold-change >2.0 and p < 0.05
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of exon per million fragments mapped (FPKM) using the Cuffdiff program from the
Cufflinks package [30]. To examine the aberrantly expressed protein-coding genes and
lncRNAs, we performed differential analysis using the Cuffdiff program. By setting
stringent criteria (FPKM > 3, fold-change >2, and p < 0.05), 5593 protein-coding genes
and 6294 lncRNAs were found to be aberrantly expressed within the group comparison
(Additional files 2, 3 and 4). Interestingly, the majority of the aberrantly expressed
novel lncRNAs are downregulated in our dataset. The potential mechanism of dysregu-
lation remains to be further explored.miRNA-binding site prediction
To establish the lncRNA–miRNA–mRNA (ceRNA) network, Targetscan 6.2 and mi-
Randa 3.3a were used for lncRNA targeted search. Using a high confidence score (see
the Materials and Methods section), the predicted MREs showed that 54 miRNAs may
interact with 83 lncRNAs (Additional file 5). Based on those 54 miRNAs, we used the
experimentally validated microRNA–target interactions database (miRTarbase) to
search for the miRNAs’ mRNA targets. The results showed that 51 miRNAs can inter-
act with 2260 targets (Additional file 6). Most of these targets are cancer-associated
genes such as PTEN, STAT3, VEGFA, KRAS, TP53, CCND1, CDK6, E2F1, FGFR1 and
EGFR, with roles in cell proliferation, apoptosis, cell cycle, invasion and metastasis.lncRNA–miRNA–mRNA ceRNA network construction
Based on the above data, the miRNA–mRNA and miRNA–lncRNA pairs were used to
construct the lncRNA–miRNA–mRNA ceRNA network using an in-house Perl script.
As shown in Fig. 2, 51 miRNAs shared 1,3623 MREs with 2260 unique genes and 82
unique lncRNAs in the ceRNA network (Additional file 7).
The ceRNA network was visualized by importing the above interactions into the
Cytoscape software to assemble the regulation network. The genes within the above
networks were further processed by gene function (GO; http://geneontology.org/) and
KEGG (http://www.genome.jp/kegg/) pathway analysis.Gene function and pathway analysis
To explore the function of our ceRNA network, the interrelated genes within the net-
work were further imported to the GO consortium and KEGG pathways for annotation
analysis. Based on BiNGO enrichment analysis [39], 325 GO functions were found to
be the significant component relating the genes in the network, involved in processes
such as small molecule metabolism, apoptosis, small GTPase-mediated signal transduc-
tion, negative regulation of apoptosis, the mitotic cell cycle, protein binding, ATP bind-
ing, DNA binding, protein kinase binding and activity, and GTP binding (Fig. 3;
Additional file 8). Functional pathways analysis demonstrated that the ceRNA network
potentially modulated multiple signaling pathways.
Pathways in cancer, such as the MAPK, Ras, regulation of actin cytoskeleton, HIF-1,
Rap1 and PI3K/Akt signaling pathway, were significantly associated with cell carcino-
genesis (Fig. 4; Additional file 9). Consistent with the role of ceRNA regulation in the
Fig. 2 The ceRNA network. Cadmium green nodes represent miRNAs; fuchsia nodes represent genes; bright
pink nodes represent lncRNAs
Fig. 3 The GO enrichment analysis of the ceRNA network
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Fig. 4 The significantly enriched KEGG terms of the ceRNA network
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function most significantly enriched within ceRNA-regulated genes (Fig. 5).
To further identify the relationship between these pathways and our ceRNA network,
a diagram of the ceRNA modulation of the PI3K/Akt signaling pathway was created to
provide useful clues regarding the mechanism associated with cell carcinogenesis.
Within the pathway, 48 unique genes were enriched. Joint analysis with lncRNAs
showed that 36 miRNAs share 1524 MREs with 48 unique genes and 59 unique
lncRNAs (Fig. 6). The genes, including PTEN, BRCA1, IL7R, EGFR, MET, ITGB4,
ITGA2, ITGA6, EPHA2,VEGFA, GRB2, KRAS, CCDN1 and TP53, encode essential sig-
naling molecules for the PTEN/PI3K/Akt pathway.Discussion
Accumulated studies have revealed that ceRNAs could serve as post-transcriptional regu-
lators of protein-coding gene expression by decoying miRNAs from other target tran-
scripts, such as lncRNAs, mRNA, pseudogenes and circular RNAs (circRNAs) [41–43].
Some studies have confirmed that ceRNAs play an important role in the regulation of
gene expression in cancers such as head and neck squamous cell carcinoma, prostate can-
cer, papillary thyroid carcinoma, pituitary gonadotrope tumors, ovarian cancer, and
chronic lymphocytic leukemia [44–46].
In this study, based on the high-throughput RNA sequencing and microarray
data, we constructed a putative ceRNA network by integrating lncRNA, miRNA
Fig. 5 PI3K/Akt signaling pathway. The PI3K/Akt signaling pathway was the most significantly enriched
biological function within the ceRNA-regulated target genes. Red nodes represent genes within the
ceRNA network
Fig. 6 The ceRNA network modulates the PI3K/Akt signaling pathway. Cadmium green nodes represent
miRNAs; fuchsia nodes represent genes; bright pink nodes represent lncRNAs
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be an independent prognostic factor associated with tumor differentiation and
location [47].
Subsequent studies reported that UCA1 could upregulate 3 target genes of miR-
204-5p (BCL2, RAB22A and CREB1) though competitive sponging of miR-204-5p,
and then promote proliferation and chemoresistance in CRC cells. [48]. Yang et al. re-
ported that the overexpressed UCA1 was correlated with metastasis of epithelial ovar-
ian cancer (EOC) and functioned as a ceRNA to suppress the expression of matrix
metallopeptidase 14 (MMP14) via competition for miR-485-5p. [49]. Chen et al. re-
ported on nuclear enriched abundant transcript 1 (NEAT1) lncRNA as a novel prog-
nostic indicator for patients with ESCC, finding that it contributes to the malignant
character of ESCC [50]. NEAT1 was also reported to be a well sponge platform for
many kinds of miRNA, such as miR-548 in the regulation of breast cancer cell apop-
tosis [51], miR-204 in regulation of epithelial-to-mesenchymal transition (EMT) and
the radioresistance of NPC cells [52], and has-mir-98-5p in regulation of EGCG-
induced CTR1 and cDDP sensitivity enhancement in NSCLC [53]. These specific fea-
tures could potentially be used to classify lncRNAs and identify those that participate
in ceRNA networks.
We found that biological function was significantly enriched with signaling path-
ways, small molecule metabolic processes, apoptotic processes, small GTPase-
mediated signal transduction, negative regulation of the apoptotic process, mitotic
cell cycle, protein binding, ATP binding, DNA binding, protein kinase binding,
protein kinase activity and GTP binding, among other things (Fig. 3; Additional file
8). These signaling pathways were often altered, especially in the cancer cells,
resulting in phenotypes of uncontrolled growth and increased capability to invade
the surrounding tissue. These crucial molecules involved in signaling pathways rep-
resent attractive targets for cancer therapy [54–57]. Agents targeting epidermal
growth factor receptor (EGFR), PI3K, and mTOR have been developed for interfer-
ing with their signaling functions.
Previous studies demonstrated that the PTEN/PI3K/Akt pathway was essential to
side population (SP) cells thanks to its involvement in the regulation of ABCG2
transporter function in primary ESCCs [22]. The PTEN/PI3K/Akt pathway plays a
modulating role in regulating stem-like cells in primary ESCCs and may provide
essential clues for the development of novel therapeutic strategies and efficient
drugs.
Consistent with these studies, we found the PI3K/Akt signaling pathway was
the most significantly enriched pathway, based on KEGG pathway analysis (Fig. 5;
Additional file 9). PTEN, a well-researched protein in cancer, encodes a plasma-
membrane lipid phosphatase that functions as a negative regulator of the PI3K/
Akt signaling pathway [58–60].
There is more evidence that both non-coding and protein-coding transcripts
regulate PTEN levels via PTEN ceRNAs and then antagonize downstream PI3K/
Akt signaling [61–64, 16]. Our analysis suggested that lncRNAs like NEAT1 and
TCONS_00287673 may upregulate PTEN though competitive sponging of miR-26a-
5p and miR-182-5p. The regulatory mechanism of these ceRNAs needs to be fur-
ther evaluated.
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